The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study

J Acquir Immune Defic Syndr. 2019 May 1;81(1):e17-e21. doi: 10.1097/QAI.0000000000001986.

¹ Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
² Clinic of Infectious Diseases, Catholic University of Sacred Heart, Roma, Italy.
³ Department of Medical Biotechnologies, University of Siena, Siena, Italy.
⁴ Clinic of Infectious Diseases, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.
⁵ Clinic of Infectious Diseases, Azienda Ospedaliera Universitaria S.Orsola Malpighi, Bologna, Italy.
⁶ Infectious Dermatology and Allergology IRCCS IFO, Roma, Italy.
⁷ Clinic of Infectious Diseases, G. D'Annunzio University, Chieti, Italy.
⁸ Infectious and Tropical Diseases Unit, DIBIC L. Sacco Hospital, University of Milano, Italy.
⁹ Infectious Diseases Unit, IRCCS S. Martino-IST, Genova, Italy.
¹⁰ Infectious Diseases Unit A, Amedeo di Savoia Hospital, Torino, Italy.
¹¹ Department of Translational and Precision Medicine, Sapienza University of Rome, Roma, Italy.
¹² Department of Public Health and Infectious Diseases, Sapienza University of Rome, Roma, Italy.
¹³ Clinic of Infectious Diseases, University of Perugia, Perugia, Italy.
¹⁴ Infectious Disease Unit, SM Goretti Hospital, Department of Public Health and Infectious Diseases, Sapienza University, Latina, Italy.
¹⁵ Infectious Diseases Unit, Pistoia Hospital, Italy.
¹⁶ Infectious Diseases Unit, Pesaro Hospital, Italy.
¹⁷ Infectious and Tropical Diseases Institute, Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy.

No abstract available

Publication types